Viridian Therapeutics, Inc.DE (Nasdaq:VRDN)

Health Care/Life Sciences • Biotechnology

CIK 1590750

Company

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Address
221 Crescent Street
Suite 401
Waltham, Massachusetts 02453

Employees
96

Stock Info

Close
$18.11

Day Range
17.92 - 19.21

52 Week Range
10.93 - 33.00

Average volume
951.14K

Short Interest
7.75M (02/15/24)

% of Float Shorted
14.21%

Market Cap
$1.2B

Revenue
$314K

Net Income
N/A

2020 Sales Growth
N/A

Rev. per Employee
$3,270.83

P/E Ratio
N/A

EPS
-$5.32

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman
Tomas Kiselak

President, Chief Executive Officer & Director
Stephen Frank Mahoney MBA

Director
Sarah Gheuens MD, PhD

Director
Jennifer K Moses CPA

Independent Director
Arlene M Morris

Independent Director
Peter Harwin

SEC filings

Date	Form	Event
16 Dec, 2024	8-K
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
12 Nov, 2024	10-Q
12 Nov, 2024	8-K
18 Oct, 2024	SC 13G/A
30 Sep, 2024	4
30 Sep, 2024	4
17 Sep, 2024	SC 13D/A
17 Sep, 2024	4
13 Sep, 2024	424B5
12 Sep, 2024	8-K
10 Sep, 2024	8-K
10 Sep, 2024	424B5
12 Aug, 2024	S-8
8 Aug, 2024	10-Q
8 Aug, 2024	8-K
15 Jul, 2024	8-K
28 Jun, 2024	4
28 Jun, 2024	4
28 Jun, 2024	4
28 Jun, 2024	4
28 Jun, 2024	4
20 Jun, 2024	8-K
10 Jun, 2024	DEFA14A
8 May, 2024	10-Q
8 May, 2024	8-K
26 Apr, 2024	ARS
26 Apr, 2024	DEFA14A
26 Apr, 2024	DEF 14A
16 Apr, 2024	8-K
1 Apr, 2024	4
1 Apr, 2024	SC 13D/A
28 Feb, 2024	S-8
27 Feb, 2024	8-K
27 Feb, 2024	10-K
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	3
14 Feb, 2024	4
13 Feb, 2024	SC 13G/A
7 Feb, 2024	4
29 Jan, 2024	SC 13G
29 Jan, 2024	SC 13G/A
24 Jan, 2024	4
24 Jan, 2024	SC 13D/A
24 Jan, 2024	SC 13G
17 Jan, 2024	424B5
12 Jan, 2024	3
10 Jan, 2024	SC 13G
8 Jan, 2024	8-K
18 Dec, 2023	8-K
18 Dec, 2023	144
12 Dec, 2023	144
8 Dec, 2023	SC 13G
7 Dec, 2023	144
1 Dec, 2023	144
30 Nov, 2023	S-3ASR
16 Nov, 2023	144
13 Nov, 2023	8-K
13 Nov, 2023	4
13 Nov, 2023	10-Q
3 Nov, 2023	SC 13D/A
2 Nov, 2023	8-K
1 Nov, 2023	3
1 Nov, 2023	3
1 Nov, 2023	4
1 Nov, 2023	4
1 Nov, 2023	4
30 Oct, 2023	8-K	CEO Change
25 Sep, 2023	8-K
25 Sep, 2023	4
25 Sep, 2023	3
19 Sep, 2023	3
12 Sep, 2023	8-K
8 Aug, 2023	S-8
8 Aug, 2023	10-Q
24 Jul, 2023	S-3ASR
17 Jul, 2023	8-K
10 Jul, 2023	8-K
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	8-K
16 Jun, 2023	4
16 Jun, 2023	4
14 Jun, 2023	SC 13D/A
6 Jun, 2023	4
2 Jun, 2023	144
11 May, 2023	SC 13G
10 May, 2023	10-Q
9 May, 2023	8-K
28 Apr, 2023	DEF 14A
28 Apr, 2023	DEFA14A
28 Apr, 2023	ARS
12 Apr, 2023	8-K
12 Apr, 2023	4
13 Mar, 2023	4
10 Mar, 2023	S-8
10 Mar, 2023	8-K
10 Mar, 2023	4
9 Mar, 2023	10-K
8 Mar, 2023	8-K
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
10 Feb, 2023	4
10 Feb, 2023	4
10 Feb, 2023	4
10 Feb, 2023	4
9 Feb, 2023	SC 13G
7 Feb, 2023	4
7 Feb, 2023	3
7 Feb, 2023	4/A
6 Feb, 2023	8-K	CEO Change
3 Feb, 2023	4
3 Feb, 2023	SC 13G
26 Jan, 2023	SC 13G/A
25 Jan, 2023	4
18 Jan, 2023	4
11 Jan, 2023	4
9 Jan, 2023	8-K
22 Dec, 2022	4
19 Dec, 2022	4
14 Dec, 2022	4
16 Nov, 2022	4
14 Nov, 2022	10-Q
9 Sep, 2022	S-3ASR
19 Aug, 2022	8-K
19 Aug, 2022	SC 13D/A
19 Aug, 2022	4
18 Aug, 2022	424B5
17 Aug, 2022	424B3
16 Aug, 2022	8-K
16 Aug, 2022	S-8
16 Aug, 2022	S-8 POS
16 Aug, 2022	S-8 POS
15 Aug, 2022	8-K
15 Aug, 2022	424B5
15 Aug, 2022	10-Q
12 Aug, 2022	SC 13G/A
24 Jun, 2022	3
23 Jun, 2022	8-K
10 Jun, 2022	4
10 Jun, 2022	4
10 Jun, 2022	8-K
10 Jun, 2022	4
10 Jun, 2022	4
2 Jun, 2022	4
31 May, 2022	SC 13G
19 May, 2022	SC 13G
13 May, 2022	10-Q
12 May, 2022	8-K
4 May, 2022	4
27 Apr, 2022	DEF 14A
27 Apr, 2022	DEFA14A
5 Apr, 2022	4
5 Apr, 2022	8-K
11 Mar, 2022	S-8
11 Mar, 2022	10-K
10 Mar, 2022	8-K
3 Mar, 2022	4
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
4 Feb, 2022	SC 13G/A
3 Feb, 2022	4
3 Feb, 2022	4
3 Feb, 2022	4
3 Feb, 2022	4
28 Jan, 2022	SC 13G/A
3 Jan, 2022	4
10 Dec, 2021	4
17 Nov, 2021	EFFECT
15 Nov, 2021	CORRESP
10 Nov, 2021	UPLOAD
8 Nov, 2021	8-K
8 Nov, 2021	S-3
5 Nov, 2021	10-Q
4 Nov, 2021	8-K
28 Oct, 2021	SC 13G
14 Oct, 2021	SC 13G
8 Oct, 2021	SC 13G/A
4 Oct, 2021	3
30 Sep, 2021	SC 13G
29 Sep, 2021	SC 13G/A
29 Sep, 2021	SC 13G/A
28 Sep, 2021	4
24 Sep, 2021	SC 13G/A
24 Sep, 2021	SC 13G
23 Sep, 2021	8-K
23 Sep, 2021	SC 13D/A
23 Sep, 2021	4
22 Sep, 2021	424B5
20 Sep, 2021	424B5
10 Sep, 2021	SC 13G
26 Aug, 2021	3
26 Aug, 2021	SC 13G
12 Aug, 2021	10-Q
11 Aug, 2021	8-K
27 Jul, 2021	3
27 Jul, 2021	4
27 Jul, 2021	3
26 Jul, 2021	8-K
15 Jul, 2021	8-K
15 Jul, 2021	3
15 Jul, 2021	4
16 Jun, 2021	4
16 Jun, 2021	4
16 Jun, 2021	4
15 Jun, 2021	8-K/A
4 Jun, 2021	DEFA14A
4 Jun, 2021	8-K
1 Jun, 2021	SC 13G/A
17 May, 2021	8-K
10 May, 2021	SC 13G
7 May, 2021	10-Q
6 May, 2021	8-K
30 Apr, 2021	DEF 14A
26 Apr, 2021	8-K
23 Apr, 2021	424B3
23 Apr, 2021	424B5
14 Apr, 2021	PRE 14A
26 Mar, 2021	10-K
26 Mar, 2021	S-8
25 Mar, 2021	8-K
15 Mar, 2021	SC 13G/A
10 Mar, 2021	SC 13G
19 Feb, 2021	SC 13G
16 Feb, 2021	SC 13G/A
16 Feb, 2021	SC 13G/A
8 Feb, 2021	4
8 Feb, 2021	4
8 Feb, 2021	4
8 Feb, 2021	4
8 Feb, 2021	4
21 Jan, 2021	4
21 Jan, 2021	3
20 Jan, 2021	4
20 Jan, 2021	8-K	CEO Change
20 Jan, 2021	4
19 Jan, 2021	SC 13G
19 Jan, 2021	4
19 Jan, 2021	4
15 Jan, 2021	4
11 Jan, 2021	SC 13G
11 Jan, 2021	SC 13G
7 Jan, 2021	SC 13G
5 Jan, 2021	SC 13D
4 Jan, 2021	8-K
21 Dec, 2020	CORRESP
21 Dec, 2020	UPLOAD
18 Dec, 2020	UPLOAD
8 Dec, 2020	CORRESP
7 Dec, 2020	UPLOAD
20 Nov, 2020	PRE 14A

Last update:2024-03-06 13:43:49.147056

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.